121 filings
Page 5 of 7
8-K
f0i09 ajfieoolartde
2 Aug 18
Zafgen Announces Departure of President and Chief Scientific Officer Dr. Thomas Hughes
4:24pm
8-K
zcgkt9 ogr
28 Jun 18
Zafgen Announces Proposed Offering of Common Stock
5:01pm
8-K
nox91mnv6xix
25 Jun 18
Zafgen Announces Positive Full Results in Phase 2Proof-of-Concept Trial ofZGN-1061 in Patients withDifficult-to-Control Type 2 Diabetes
7:15am
8-K
fqpxt 06r
7 Jun 18
Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors
5:06pm
8-K
hmb250gahowydaxkp
30 May 18
Zafgen, Inc. Expands Executive Leadership Team with Appointment of
5:17pm
8-K
8g893aujy9c1kj5y
8 May 18
Zafgen Reports First Quarter 2018 Operating and Financial Results
4:09pm
8-K
xugrr liu2out
6 Mar 18
Results of Operations and Financial Condition
12:00am
8-K
c3rv7e70l8
5 Jan 18
Zafgen Reports Strong Clinical Progress and Updates Outlook for 2018
12:00am
8-K
kmbl4kn1 qc1opsz
7 Nov 17
Zafgen Reports Third Quarter 2017 Financial Results
12:00am
8-K
7r5zzyri
12 Oct 17
Zafgen Appoints Jeffrey Hatfield as Chief Executive Officer; Thomas Hughes, Ph.D. to Continue as President, Appointed Chief Scientific Officer
12:00am
8-K
9tr1q
8 Aug 17
Zafgen Reports Second Quarter 2017 Financial Results
12:00am
8-K
gd6eige2
23 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
cz8oez7p2r0 rcu
9 May 17
Zafgen Reports First Quarter 2017 Financial Results
12:00am
8-K
u0mvpeaq fk849qad4
4 May 17
Zafgen Announces Positive Topline Phase 1 Data for ZGN-1061, a Second Generation MetAP2 Inhibitor
12:00am
8-K
c0h8p1mte hrovb2d
9 Mar 17
Zafgen Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
p7cjciqil
9 Nov 16
Zafgen Reports Third Quarter 2016 Financial Results
12:00am
8-K
z1845dx63g0
4 Aug 16
Zafgen Reports Second Quarter 2016 Financial Results
12:00am
8-K
m9ilbwgtd rt84u
19 Jul 16
Zafgen Refocuses Resources on Development of Differentiated Second-Generation MetAP2 Inhibitor ZGN-1061
12:00am
8-K
esn9g53q0d01 dm
1 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
x2wgh2ads
10 May 16
Zafgen Reports First Quarter 2016 Financial Results
12:00am